FTC Requires Divestiture In $12.8B Acquisition

Law360, New York (October 17, 2006, 12:00 AM EDT) -- In a move to win regulatory approval for its proposed acquisition of a rival laboratory equipment maker, Thermo Electron Corp. has agreed to sell off Fisher Scientific International Inc.’s Genevac division, quelling the Federal Trade Commission’s opposition to the $12.8 billion deal.

The FTC had complained that the acquisition would stifle competition and innovation in the market for high-performance centrifugal vacuum evaporators. Thermo Electron and Fisher are the only two significant suppliers of centrifugal vacuum evaporators in the United States.

By divesting the Genevac division, Thermo...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.